SUBJECT-32226.dossier · institution · status: active
U(
subject of file

US Food and Drug Administration (FDA)

Tracked because Institution with influence over public policy or connected to tracked entities · 6 documented connections
Editorial summary · AI-drafted from public records

US Food and Drug Administration (FDA)

Facts on record0
Connections mapped6
Sources cited5
✦ Thin coverage gap +20 connected to 6 entities · only 0 facts on record · flagged for follow-up research
⚠ no sources
Network web → Timeline → Compare with… → Position Drift → Coverage tone → View on Graph → Export CSV JSON Dossier ← Entity Directory
Stated vs Revealed
No documented contradictions on file.
[PUBLIC COST ESTIMATE]
At least $2.4M in documented public funds flow through entities connected to this profile, while 2 elected officials hold documented connections.
$10.7BContract Value
1Money Chains
1Traced Hops
Connected Officials
Calculation Methodology

Contract values are summed from documented money flow chains where this entity appears as a source or destination node. Amounts are drawn from USASpending.gov, FEC filings, SEC EDGAR, or LD-2 lobbying registrations.

Donor contributions aggregate documented amounts from the donor_interests table, sourced from FEC individual and PAC contribution filings.

Connected officials are elected officials in our database with a mapped relationship (lobbying, board membership, campaign contribution, etc.) to this entity.

Annualised flow represents the total documented dollar amount traced through money flow hops involving this entity. Where hop-level amounts are unavailable, the chain-level documented total is used as a conservative upper bound.

All figures are drawn from public filings. Estimates are conservative — undisclosed transactions, dark money, and vanish-point hops are excluded from totals. This is a minimum documented floor, not a ceiling.

PATTERN organization → [donor] → person → [oversight] → institution 6218× PATTERN person → [oversight] → institution 91× PATTERN organization → [donor] → person → [congressional committe... 60× PATTERN institution → [congressional committee role] → person → [... 60× PATTERN company → [oversight] → institution → [oversight] → person 46×
Connection Map
Key Connections
← Purdue Pharma company
oversight
Purdue Pharma's opioid products (e.g., OxyContin) were approved and regulated by the FDA.
← Sackler Family family
oversight
The FDA approved OxyContin, manufactured by Purdue Pharma (owned by the Sackler Family), and later regulated the drug's labeling and marketing.
← Blackrock Neurotech company
regulator
The FDA granted Breakthrough Device Designation to Blackrock Neurotech's MoveAgain system in 2021. The FDA also cleared the Utah Array in 2004 for temporary (≤30 days) monitoring.
← Julia Letlow person
oversight
Serves on House Appropriations subcommittee for Agriculture, Rural Development, and FDA, giving her oversight over the agency
← Andy Harris person
congressional_committee_role
As chair of the House Appropriations Subcommittee on Agriculture, Rural Development, and FDA, Harris has direct oversight of FDA funding.
Facts (0)
No facts yet.
All Connections (6)
← Blackrock Neurotech company
regulator primary since 2004
The FDA granted Breakthrough Device Designation to Blackrock Neurotech's MoveAgain system in 2021. The FDA also cleared the Utah Array in 2004 for temporary (≤30 days) monitoring.
← Andy Harris person
congressional_committee_role primary since 2026
As chair of the House Appropriations Subcommittee on Agriculture, Rural Development, and FDA, Harris has direct oversight of FDA funding.
← Sackler Family Trusts (Offshore) financial vehicle
oversight secondary since unknown
Purdue Pharma and the Sackler family were subject to FDA regulation and enforcement actions related to OxyContin marketing and opioid crisis.
← Julia Letlow person
oversight primary since 2023
Serves on House Appropriations subcommittee for Agriculture, Rural Development, and FDA, giving her oversight over the agency
← Purdue Pharma company
oversight primary since 1995
Purdue Pharma's opioid products (e.g., OxyContin) were approved and regulated by the FDA.
← Sackler Family family
oversight primary since 1995
The FDA approved OxyContin, manufactured by Purdue Pharma (owned by the Sackler Family), and later regulated the drug's labeling and marketing.
Money Flows Passing Through (1)
Documented payment chains where this entity appears as a source, hop, or vanish point. All chains →
active 3 hops ⚠ 1 vanish USD 10700000000.00
Purdue Pharma → Sackler Family → Offshore Trusts
Sources (5)
2026-05-10 UNVERIFIED SEARCH_ERROR: US Food and Drug Administration (FDA) not found in opencorporates claim_flag Processed 📜 Receipt
2026 UNVERIFIED Research: US Food and Drug Administration (FDA) — Parliamentary records (no resu… parliamentary_record Processed 📜 Receipt
2026 UNVERIFIED Research: US Food and Drug Administration (FDA) — USASpending contracts (no resu… contract Processed 📜 Receipt
2026 UNVERIFIED Research: US Food and Drug Administration (FDA) — Court records (no results) court_document Processed 📜 Receipt
2026 UNVERIFIED Research: US Food and Drug Administration (FDA) — Lobbying disclosures (no resul… government_disclosure Processed 📜 Receipt